| Novel therapeutic applications of cardiac glycosides I Prassas, EP Diamandis Nature reviews Drug discovery 7 (11), 926-935, 2008 | 770 | 2008 |
| COVID-19: from an acute to chronic disease? Potential long-term health consequences V Higgins, D Sohaei, EP Diamandis, I Prassas Critical reviews in clinical laboratory sciences 58 (5), 297-310, 2021 | 355 | 2021 |
| Unleashing the therapeutic potential of human kallikrein-related serine proteases I Prassas, A Eissa, G Poda, EP Diamandis Nature reviews Drug discovery 14 (3), 183-202, 2015 | 246 | 2015 |
| Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis GS Karagiannis, C Petraki, I Prassas, P Saraon, N Musrap, ... Oncotarget 3 (3), 267, 2012 | 146 | 2012 |
| Validation of biomarkers that complement CA19. 9 in detecting early pancreatic cancer A Chan, I Prassas, A Dimitromanolakis, RE Brand, S Serra, EP Diamandis, ... Clinical Cancer Research 20 (22), 5787-5795, 2014 | 140 | 2014 |
| Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ... Molecular & Cellular Proteomics 12 (10), 2820-2832, 2013 | 110 | 2013 |
| Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks I Prassas, GS Karagiannis, I Batruch, A Dimitromanolakis, A Datti, ... Molecular cancer therapeutics 10 (11), 2083-2093, 2011 | 95 | 2011 |
| An overview of mental health during the COVID-19 pandemic PJ Chen, Y Pusica, D Sohaei, I Prassas, EP Diamandis Diagnosis 8 (4), 403-412, 2021 | 86 | 2021 |
| Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry D Cretu, I Prassas, P Saraon, I Batruch, R Gandhi, EP Diamandis, ... Clinical proteomics 11, 1-12, 2014 | 67 | 2014 |
| Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery I Prassas, CC Chrystoja, S Makawita, EP Diamandis BMC medicine 10, 1-13, 2012 | 67 | 2012 |
| Proteomic and peptidomic analysis of human sweat with emphasis on proteolysis Y Yu, I Prassas, CMJ Muytjens, EP Diamandis Journal of proteomics 155, 40-48, 2017 | 61 | 2017 |
| Evaluation of a transfer medium containing high concentration of hyaluronan in human in vitro fertilization KE Loutradi, I Prassas, E Bili, T Sanopoulou, I Bontis, BC Tarlatzis Fertility and sterility 87 (1), 48-52, 2007 | 52 | 2007 |
| Novel outcome biomarkers identified with targeted proteomic analyses of plasma from critically ill coronavirus disease 2019 patients DD Fraser, G Cepinskas, EK Patterson, M Slessarev, C Martin, M Daley, ... Critical care explorations 2 (9), e0189, 2020 | 51 | 2020 |
| False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125 I Prassas, D Brinc, S Farkona, F Leung, A Dimitromanolakis, CC Chrystoja, ... Clinical Chemistry 60 (2), 381-388, 2014 | 49 | 2014 |
| High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies I Prassas, M Paliouras, A Datti, EP Diamandis Clinical Cancer Research 14 (18), 5778-5784, 2008 | 39 | 2008 |
| Novel biological substrates of human kallikrein 7 identified through degradomics Y Yu, I Prassas, A Dimitromanolakis, EP Diamandis Journal of Biological Chemistry 290 (29), 17762-17775, 2015 | 36 | 2015 |
| Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer D Korbakis, A Dimitromanolakis, I Prassas, GJ Davis, E Barber, ... British journal of cancer 113 (3), 484-491, 2015 | 35 | 2015 |
| Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research I Prassas, EP Diamandis Clinical Chemistry and Laboratory Medicine (CCLM) 52 (6), 765-766, 2014 | 34 | 2014 |
| Proteogenomics: opportunities and caveats L Dimitrakopoulos, I Prassas, EP Diamandis, A Nesvizhskii, T Kislinger, ... Clinical chemistry 62 (4), 551-557, 2016 | 29 | 2016 |
| In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers GS Karagiannis, MP Pavlou, P Saraon, N Musrap, A Xie, I Batruch, ... Journal of proteomics 103, 121-136, 2014 | 29 | 2014 |
